Induction of antibodies against GM2 ganglioside by immunizing melanoma patients using GM2-keyhole limpet hemocyanin + QS21 vaccine: A dose-response study

Clinical Cancer Research

Volumn 6, Issue 3, 2000, Pages 874-879

  Chapman, Paul B ^a   Morrissey, D M ^b   Panageas, K S ^a   Hamilton, W B ^b   Zhan, C ^b   Destro, A N ^a   Williams, L ^a   Israel, R J ^b   Livingston, P O ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b A Subsidiary of Lantheus Holdings   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE ANTIBODY; GANGLIOSIDE GM2; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KEYHOLE LIMPET HEMOCYANIN; MELANOMA VACCINE; QS 21;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DOSE RESPONSE; FEMALE; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL;

ADULT; AGED; ANIMALS; ANTIBODY FORMATION; CANCER VACCINES; CATTLE; DOSE-RESPONSE RELATIONSHIP, DRUG; FATIGUE; FEMALE; FEVER; G(M2) GANGLIOSIDE; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLAMMATION; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; PAIN; PRURITUS; TIME FACTORS; TUMOR CELLS, CULTURED; VACCINES, CONJUGATE;

EID: 0034017617     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Tai, T., Cahan, L. D., Tsuchida, T., Saxton, R. E., Irie, R. F., and Morton, D. L. Immunogenicity of melanoma-associated gangliosides in cancer patients. Int. J. Cancer, 35: 607-612, 1985.
2. Livingston, P. O., Ritter, G., Oettgen, H. F., and Old, L. J. Immunization of melanoma patients with purified gangliosides. In: H. F. Oettgen (ed.), Gangliosides and Cancer, pp. 293-300. New York: VCH Publishers, Inc., 1989.
3. Livingston, P. O., Wong, G. Y. C., Adluri, S., Tao, Y., Padavan, M., Parente, R., Hanlon, C., Jones Calves, M., Helling, F., Ritter, G., Oettgen, H. F., and Old, L. J. Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside. J. Clin. Oncol., 12: 1036-1044, 1994.
4. Livingston, P. O., Natoli, E. J., Jr., Calves, M. J., Stockert, E., Oettgen, H. F., and Old, L. J. Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients. Proc. Natl. Acad. Sci. USA, 84: 2911-2915, 1987.
5. Helling, F., Zhang, S., Shang, A., Adluri, S., Calves, M., Koganty, R., Longenecker, B. M., Yao, T-J., Oettgen, H. F., and Livingston, P. O. GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21. Cancer Res., 55: 2783-2788, 1995.
6. Kensil, C. R., Patel, U., Lennick, M., and Marciani, D. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex. J. Immunol., 146: 431-437, 1991.
7. Livingston, P. O., Adluri, S., Helling, F., Yao, T. J., Kensil, C. R., Newman, M. J., and Marciani, D. Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma. Vaccine, 12: 1275-1280, 1994.
8. Livingston, P., Zhang, S., Adluri, S., Yao, T-J., Graeber, L., Ragupathi, G., Helling, F., and Fleisher, M. Tumor cell reactivity mediated by IgM antibodies in sera from melanoma patients vaccinated with GM2 ganglioside covalently linked to KLH is increased by IgG antibodies. Cancer Immunol. Immunother., 43: 324-330, 1997.
9. Helling, F., Shang, A., Calves, M., Zhang, S., Ren, S., Yu, R. K., Oettgen, H. F., and Livingston, P. O. Increased immunogenicity of GD3 conjugate vaccines: comparison of various carrier proteins and selection of GD3-KLH for further testing. Cancer Res., 54: 197-203, 1994.
10. Creekmore, S. P., Longo, D. L., and Urba, W. J. Principles of the clinical evaluation of biologic agents. In: V. T. J. DeVita, S. Hellman, and S. A. Rosenberg (eds.), Biologic Therapy of Cancer, pp. 67-86. Philadelphia: J. B. Lippincott Company, 1991.